top of page

Randomised trial of one-session virtual reality exposure therapy for blood-injection-injury phobias

  • Writer: Lucy Rohatynchuk
    Lucy Rohatynchuk
  • Jan 31, 2022
  • 1 min read

Authors conducted a randomized controlled trial to examine the acceptability and efficacy of a single-session virtual reality exposure therapy (VRET) intervention for blood-injection-injury (BII) phobias. Participants completed self-report measures of BII severity (Medical Fear Survey [MFS] and Multidimensional Blood Phobia Inventory [MBPI]) and dental anxiety (Modified Dental Anxiety Scale), and clinician ratings of BII phobia severity and catastrophic cognitions at baseline, one-week post-treatment, and 3-month follow-up. Researchers found moderate to large differences favouring VRET on the MBPI Injection and Injury fears subscales (g's=0.64–1.14) at one-week post-treatment and 3-month follow-up, and on the MBPI Fainting subscale (g = 0.84) and Injections subscale of the Medical Fear Survey (g = 0.63) at follow-up. In conclusion, there is some evidence to suggest that a single-session VRET may provide improvements in fears of injections, injury, and fainting.


Citation:

Jiang, M. Y. W., Upton, E., & Newby, J. M. (2020). A randomised wait-list controlled pilot trial of one-session virtual reality exposure therapy for blood-injection-injury phobias. Journal of Affective Disorders, 276, 636–645.

https://doi-org.ezproxy.library.uvic.ca/10.1016/j.jad.2020.07.076


Open access: https://www.sciencedirect.com/science/article/pii/S0165032720325210


Comments


UVic Students Above Stigma

We acknowledge and respect the lək̓ʷəŋən peoples on whose traditional territory the University of Victoria stands, and the Songhees, Esquimalt and W̱SÁNEĆ peoples whose historical relationships with the land continue to this day.

  • Facebook
  • Instagram
bottom of page